Annual Cash & Cash Equivalents
$381.39 M
+$226.01 M+145.45%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual cash & cash equivalents is $381.39 million, with the most recent change of +$226.01 million (+145.45%) on December 31, 2023.
- During the last 3 years, PHAT annual cash & cash equivalents has risen by +$93.90 million (+32.66%).
- PHAT annual cash & cash equivalents is now at all-time high.
Performance
PHAT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$334.68 M
+$58.44 M+21.16%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly cash and cash equivalents is $334.68 million, with the most recent change of +$58.44 million (+21.16%) on September 30, 2024.
- Over the past year, PHAT quarterly cash and cash equivalents has increased by +$58.44 million (+21.16%).
- PHAT quarterly cash and cash equivalents is now -12.25% below its all-time high of $381.39 million, reached on December 31, 2023.
Performance
PHAT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PHAT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +145.4% | +21.2% |
| 3 y3 years | +32.7% | +115.4% |
| 5 y5 years | +10000.0% | +115.4% |
PHAT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.4% | -12.3% | +158.3% |
| 5 y | 5-year | at high | +145.4% | -12.3% | +158.3% |
| alltime | all time | at high | >+9999.0% | -12.3% | >+9999.0% |
Phathom Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $334.68 M(+21.2%) |
| Jun 2024 | - | $276.24 M(-14.3%) |
| Mar 2024 | - | $322.23 M(-15.5%) |
| Dec 2023 | $381.39 M(+145.5%) | $381.39 M(+78.5%) |
| Sep 2023 | - | $213.68 M(-14.1%) |
| Jun 2023 | - | $248.85 M(+92.1%) |
| Mar 2023 | - | $129.57 M(-16.6%) |
| Dec 2022 | $155.38 M(-15.2%) | $155.38 M(-21.1%) |
| Sep 2022 | - | $196.84 M(-5.1%) |
| Jun 2022 | - | $207.39 M(+50.2%) |
| Mar 2022 | - | $138.09 M(-24.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $183.26 M(-36.3%) | $183.26 M(-18.4%) |
| Sep 2021 | - | $224.62 M(+7.1%) |
| Jun 2021 | - | $209.67 M(-11.9%) |
| Mar 2021 | - | $237.97 M(-17.2%) |
| Dec 2020 | $287.50 M(+17.9%) | $287.50 M(+27.0%) |
| Sep 2020 | - | $226.36 M(-8.5%) |
| Jun 2020 | - | $247.27 M(-3.7%) |
| Mar 2020 | - | $256.67 M(+5.3%) |
| Dec 2019 | $243.76 M(>+9900.0%) | $243.76 M(+227.3%) |
| Sep 2019 | - | $74.48 M(-10.2%) |
| Jun 2019 | - | $82.92 M(+9333.1%) |
| Dec 2018 | $879.00 K | $879.00 K |
FAQ
- What is Phathom Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Phathom Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Phathom Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of PHAT is $381.39 M
What is the all time high annual cash & cash equivalents for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual cash & cash equivalents is $381.39 M
What is Phathom Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, PHAT annual cash & cash equivalents has changed by +$226.01 M (+145.45%)
What is Phathom Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PHAT is $334.68 M
What is the all time high quarterly cash and cash equivalents for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly cash and cash equivalents is $381.39 M
What is Phathom Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, PHAT quarterly cash and cash equivalents has changed by +$58.44 M (+21.16%)